DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients' clinical management and be a therapeutic target?
- PMID: 30705846
- PMCID: PMC6328690
- DOI: 10.21037/tlcr.2018.12.06
DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients' clinical management and be a therapeutic target?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration.Commun Biol. 2018;1:43. doi: 10.1038/s42003-018-0050-6. Epub 2018 May 3. Commun Biol. 2018. PMID: 29782621 Free PMC article.
References
-
- El-Rifai W, Smith MF, Jr, Li G, et al. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res 2002;62:4061-4. - PubMed
Publication types
LinkOut - more resources
Full Text Sources